Proto Labs [PRLB] vs CompoSecure [CMPOW] Detailed Stock Comparison
Proto Labs
NYSE
Loading...
CompoSecure
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Proto Labs wins in 4 metrics, CompoSecure wins in 11 metrics, with 0 ties. CompoSecure appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Proto Labs | CompoSecure | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 77.70 | N/A | N/A |
| Price-to-Book Ratio | 1.67 | N/A | N/A |
| Debt-to-Equity Ratio | 0.43 | 0.00 | CompoSecure |
| PEG Ratio | 31.71 | N/A | N/A |
| EV/EBITDA | 17.58 | 8.95 | CompoSecure |
| Profit Margin (TTM) | 2.91% | -28.15% | Proto Labs |
| Operating Margin (TTM) | 3.79% | 17.95% | CompoSecure |
| EBITDA Margin (TTM) | 3.79% | 17.95% | CompoSecure |
| Return on Equity | 2.19% | 37.45% | CompoSecure |
| Return on Assets (TTM) | 1.86% | 11.33% | CompoSecure |
| Free Cash Flow (TTM) | $68.66M | $121.11M | CompoSecure |
| 1-Year Return | 64.62% | 481.60% | CompoSecure |
| Price-to-Sales Ratio (TTM) | 2.19 | 2.26 | Proto Labs |
| Enterprise Value | $1.01B | $1.08B | CompoSecure |
| EV/Revenue Ratio | 1.99 | 2.56 | Proto Labs |
| Gross Profit Margin (TTM) | 44.26% | 48.06% | CompoSecure |
| Revenue per Share (TTM) | $21 | $3 | Proto Labs |
| Earnings per Share (Diluted) | $0.60 | N/A | N/A |
| Beta (Stock Volatility) | 1.33 | 0.97 | CompoSecure |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Proto Labs vs CompoSecure Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Proto Labs | 0.71% | 7.94% | 14.52% | 15.97% | 10.29% | 20.31% |
| CompoSecure | 46.07% | 57.74% | 45.62% | 120.47% | 118.94% | 103.87% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Proto Labs | 64.62% | 0.41% | -64.70% | -37.37% | 60.76% | 60.76% |
| CompoSecure | 481.60% | 1,042.17% | 148.17% | 53.40% | 28.28% | 28.28% |
Performance & Financial Health Analysis: Proto Labs vs CompoSecure
| Metric | PRLB | CMPOW |
|---|---|---|
| Market Information | ||
| Market Cap | $1.11B | $952.39M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 241,390 | 43,726 |
| 90 Day Avg. Volume | 196,843 | 34,127 |
| Last Close | $46.62 | $9.48 |
| 52 Week Range | $26.35 - $48.00 | $3.79 - $9.51 |
| % from 52W High | -2.88% | -0.32% |
| All-Time High | $286.57 (Jan 25, 2021) | $14.51 (Jan 08, 2018) |
| % from All-Time High | -83.73% | -34.67% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | -0.41% |
| Quarterly Earnings Growth | -0.03% | -0.42% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | -0.28% |
| Operating Margin (TTM) | 0.04% | 0.18% |
| Return on Equity (TTM) | 0.02% | 0.37% |
| Debt to Equity (MRQ) | 0.43 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $27.84 | $-1.04 |
| Cash per Share (MRQ) | $4.32 | $0.05 |
| Operating Cash Flow (TTM) | $71.01M | $66.60M |
| Levered Free Cash Flow (TTM) | $64.86M | $159.49M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Proto Labs vs CompoSecure
| Metric | PRLB | CMPOW |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 77.70 | N/A |
| Forward P/E | 31.71 | N/A |
| PEG Ratio | 31.71 | N/A |
| Price to Sales (TTM) | 2.19 | 2.26 |
| Price to Book (MRQ) | 1.67 | N/A |
| Market Capitalization | ||
| Market Capitalization | $1.11B | $952.39M |
| Enterprise Value | $1.01B | $1.08B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.99 | 2.56 |
| Enterprise to EBITDA | 17.58 | 8.95 |
| Risk & Other Metrics | ||
| Beta | 1.33 | 0.97 |
| Book Value per Share (MRQ) | $27.84 | $-1.04 |
Financial Statements Comparison: Proto Labs vs CompoSecure
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PRLB | CMPOW |
|---|---|---|
| Revenue/Sales | $135.06M | $59.82M |
| Cost of Goods Sold | $75.29M | $31.08M |
| Gross Profit | $59.77M | $28.75M |
| Research & Development | $11.17M | N/A |
| Operating Income (EBIT) | $5.12M | $6.04M |
| EBITDA | $13.84M | $7.81M |
| Pre-Tax Income | $6.67M | $33.65M |
| Income Tax | $2.25M | $27.00M |
| Net Income (Profit) | $4.43M | $21.49M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PRLB | CMPOW |
|---|---|---|
| Cash & Equivalents | $82.69M | $9.51M |
| Total Current Assets | $194.41M | $10.83M |
| Total Current Liabilities | $62.09M | $47.09M |
| Long-Term Debt | $1.70M | $0 |
| Total Shareholders Equity | $656.80M | $-87.31M |
| Retained Earnings | $236.55M | $-293.59M |
| Property, Plant & Equipment | $224.29M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PRLB | CMPOW |
|---|---|---|
| Operating Cash Flow | $11.14M | $9.71M |
| Capital Expenditures | $-1.26M | $0 |
| Free Cash Flow | $17.12M | $2.62M |
| Debt Repayment | $-76,000 | $0 |
| Common Stock Repurchase | $-22.14M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PRLB | CMPOW |
|---|---|---|
| Shares Short | 656,829 | N/A |
| Short Ratio | 3.78 | N/A |
| Short % of Float | 0.04% | N/A |
| Average Daily Volume (10 Day) | 241,390 | 43,726 |
| Average Daily Volume (90 Day) | 196,843 | 34,127 |
| Shares Outstanding | 24.23M | 100.46M |
| Float Shares | 23.60M | 36.10M |
| % Held by Insiders | 0.01% | N/A |
| % Held by Institutions | 0.94% | N/A |
Dividend Analysis & Yield Comparison: Proto Labs vs CompoSecure
| Metric | PRLB | CMPOW |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |